Author

Koustav Singha

Institution: North Bengal University

Observed institution: North Bengal University

ORCID: 0009-0008-8830-0687

Observed ORCID: 0009-0008-8830-0687

OpenAlex ID: A5010139330

FDA-approved heterocyclic molecules for cancer treatment: Synthesis, dosage, mechanism of action and their adverse effect

2023 · Mossaraf Hossain, Imran Habib, et al. · Heliyon · 77

Recent Progress on Pyridine N ‐Oxide in Organic Transformations: A Review

2023 · Imran Habib, Koustav Singha, et al. · ChemistrySelect · 50

Quinoline N‐Oxide: A Versatile Precursor in Organic Transformations

2022 · Koustav Singha, Imran Habib, et al. · ChemistrySelect · 22

Functionalization of imidazole N -oxide: a recent discovery in organic transformations

2022 · Koustav Singha, Imran Habib, et al. · Beilstein Journal of Organic Chemistry · 12

Transition metal-free C–H activation of heteroarenes: an overview (2018–2022)

2022 · Imran Habib, Koustav Singha, et al. · Synthetic Communications · 9

Bovine serum albumin: an effective and eco-friendly biocatalyst for one-pot, three-component synthesis of valuable imidazole N -oxides in H 2 O–EtOH medium

2026 · Koustav Singha, Imran Habib, et al. · Organic & Biomolecular Chemistry · 1

Synthesis of 2‐Acetoxyimidazole Derivatives as Potent Cytotoxic Agents in the MCF‐7 Cancer Cell Line

2026 · Mossaraf Hossain, Imran Habib, et al. · ChemistrySelect

Design and Synthesis of Pyrimidine-Based Heteroaryl Compounds and their Applications for the Treatment of Cancer

2026 · Koustav Singha, Imran Habib, et al. · Current Organic Chemistry

Cytotoxicity evaluation and DNA binding studies of 1,3-dihydroxy-2-(4-methoxyphenyl)-4,5-dimethyl-1H-imidazol-3-ium chloride beyond its structural and Hirshfeld surface analysis, spectroscopic investigations, vibrational assignments and theoretical characterizations

2026 · Munna Mukhia, Sumiran Tamang, et al. · European Journal of Chemistry

Works count: 9

Citation count: 171

H-index: 5

I10-index: 4